<?xml version="1.0" encoding="UTF-8"?>
<p id="Par75">The treatment of chronic hepatitis C virus infection has been revolutionized thanks to the recent development of the new oral direct-acting antiviral agents. DAAs increase the likelihood of cure with a shorter duration of treatment and a better safety profile compared to previously used IFN-based regimens.</p>
